Skip to main content
Premium Trial:

Request an Annual Quote

The BioCommerce Week Index: May 12, 2005

BioCommerce Week’s Index to the
Diversified Molecular Biology Tools Companies
Company
Ticker
Current Price
(
May 10, 2005)
Last Price
(
May 3, 2005)
% Change
Agilent
A
21.86
21.18
3.21
Applied Biosystems
ABI
22.45
22.62
-0.75
BD
BDX
59.17
59.17
0.00
Beckman
BEC
66.38
67.04
-0.98
Bio-Rad
BIO
52.58
49.62
5.97
Bruker
BRKR
3.54
3.4
4.12
GE
GE
35.83
36.1
-0.75
Harvard Bio
HBIO
3.4
3.82
-10.99
Invitrogen
IVGN
76.52
75.2
1.76
Molecular Devices
MDCC
18.81
18.42
2.12
PerkinElmer
PKI
18.88
18.01
4.83
Sigma
SIAL
59.54
59.44
0.17
Stratagene
STGN
9.19
8.2
12.07
Thermo
TMO
26.15
25.41
2.91
Waters
WAT
40.03
39.83
0.50
Index Average
34.29
33.83
1.35

Stratagene Boasts Biggest Gain in This Week's BCW Index

Stratagene's shares rose 12 percent to $9.19 during the five-day period ending Tuesday, far outgaining any of the other 14 companies that comprise the BioCommerce Week Index, a basket of multiplatform molecular biology tools companies. The gains for the firm were steady during the tracking period and surrounded the release on Tuesday of its Q1 financial results, which showed a 27-percent increase in Q1 revenues and beat out analysts' consensus estimate for the quarter.

The biggest decline of the week belonged to Harvard Bioscience, whose shares dropped roughly 11 percent. The firm's stock dropped steadily over the three-day period following the release of its first-quarter results. Harvard Bio reported a 1-percent increase in first-quarter revenue, and executives of the firm called the results "disappointing" in a conference call (see article on HBIO in this week's issue).

Overall, the BCW Index gained 1.35 percent to close at $34.29 on Tuesday, up for the third week in a row. The Index outgained the Dow Jones Industrial Average, which rose .2 percent, but trailed the Nasdaq, which gained 1.5 percent. The Nasdaq Biotech Index posted a sharp 4.3 percent gain for the tracking period.

The Scan

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.

Study Tracks Outcomes in Children Born to Zika Virus-Infected Mothers

By following pregnancy outcomes for women with RT-PCR-confirmed Zika virus infections, researchers saw in Lancet Regional Health congenital abnormalities in roughly one-third of live-born children.

Team Presents Benchmark Study of RNA Classification Tools

With more than 135 transcriptomic datasets, researchers tested two dozen coding and non-coding RNA classification tools, establishing a set of potentially misclassified transcripts, as they report in Nucleic Acids Research.

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.